Manufacturing and Production

Showing 15 posts of 5882 posts found.

uday_baldota

Taro announces appointment of new CEO

November 25, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …
shutterstock_231613360

Non-small cell lung cancer market to hit $26bn by 2025

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …
navidea_cmyk

Navidea agrees deal worth $310 million with Cardinal

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cardinal, Navidea, Navidea biopharmaceutical

Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …
juno

Patient deaths lead Juno Therapeutics to halt trial for second time

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics

Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …
lilly2_web

Lilly forced to abandon Alzheimer’s drug after failed trial

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly

Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …
allergan

Allergan acquires Chase Pharma in potential $1 billion deal

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …
anthony_maddaluna

Anthony Maddaluna, executive vice president of Pfizer, to retire

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …

Pfizer set to develop new $200 million site

November 23, 2016 Manufacturing and Production, Research and Development Pfizer, manufacturing and production

Pfizer plans to expand its operations in St. Louis, Missouri, by developing a $200 million facility in Chesterfield. The site …
thomas_willemsen

Thomas Willemson promoted to China Area Head at GSK

November 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …
jj_2johnson_and_johnson

J&J and Genmab’s drug races to second line treatment approval

November 22, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Genmab, Janssen, Johnson & Johnson, darzalex, multiple myeloma

Janssen, a part of Johnson & Johnson, and Genmab have announced that their multiple myeloma drug Darzalex (daratumumab) has been …

Mylan ducks call to testify in front of Senate

November 22, 2016 Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …
fdaoutsideweb

Sanofi and Novo to face off in diabetes sphere following FDA approvals

November 22, 2016 Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes

Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …
astrazeneca_building_white

AstraZeneca allowed to recruit for drug trial again

November 22, 2016 Manufacturing and Production, Research and Development AstraZeneca, FDA, clinical trial

AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …
theresa_may

Theresa May promises £2 billion a year in funding for R&D

November 21, 2016 Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit

The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …

Acorda forced to stop development of drug

November 21, 2016 Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke

Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …
The Gateway to Local Adoption Series

Latest content